Characterization, blood profile and biodistribution properties of surface modified PLGA nanoparticles of SN-38

International Journal of Pharmaceutics

Volumn 406, Issue 1-2, 2011, Pages 122-127

  Ebrahimnejad, Pedram ^a,b   Dinarvand, Rassoul ^a   Jafari, Mahmoud Reza ^c   Tabasi, Seyed Abolghasem Sajadi ^d   Atyabi, Fatemeh ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Biodistribution; Folate targeting; Nanoparticle; Nanotechnology; Pegylation; PLGA; SN 38

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; FOLIC ACID; MACROGOL; NANOPARTICLE; POLYGLACTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; CONTROLLED STUDY; COVALENT BOND; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RELEASE; DRUG SYNTHESIS; IN VIVO STUDY; KIDNEY; LIVER; LUNG; NONHUMAN; PARTICLE RESUSPENSION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SPLEEN; SURFACE PROPERTY; ZETA POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; FOLIC ACID; INJECTIONS, INTRAVENOUS; LACTIC ACID; MOLECULAR STRUCTURE; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; RATS; RATS, WISTAR; SURFACE PROPERTIES; TISSUE DISTRIBUTION;

EID: 79951577793     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.12.022     Document Type: Article

References (34)

1. F. Atyabi, A. Farkhondehfai, F. Esmaeili, and R. Dinarvand Preparation of pegylated nano-liposomal formulation containing SN-38: in vitro characterization and in vivo biodistribution in mice Acta Pharm. 59 2009 133 144
2. D.J. Bharali, V. Pradhan, G. Elkin, W. Qi, A. Hutson, and S.A. Mousa Novel nanoparticles for the delivery of recombinant hepatitis B vaccine Nanomedicine: NBM. 4 2008 311 317
3. I. Brigger, C. Dubernet, and P. Couvreur Nanoparticles in cancer therapy and diagnosis Adv. Drug Deliv. Rev. 54 2002 631 651 (Pubitemid 35247520)
4. R. Carbonero, and J. Supko Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins Clin. Cancer Res. 8 2002 641 661 (Pubitemid 34742090)
5. S.S. Chakravarthi, S. De, D.W. Miller, and D.H. Robinson Comparison of antitumour efficacy of paclitaxel delivered in nano- and microparticles Int. J. Pharm. 383 2010 37 44
6. N. Chiannilkulchai, N. Ammoury, B. Caillou, J. Devissaguet, and P. Couvreur Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcomaM5076 metastasis-bearing mice Cancer Chemother. Pharmacol. 26 1990 122 126 (Pubitemid 20153803)
7. P. Ebrahimnejad, R. Dinarvand, S.A. Sajadi, F. Atyabi, F. Ramezani, and M.R. Jafari Preparation and characterization of poly lactide-co-glycolide nanoparticles of SN-38 PDA J. Pharm. Sci. Tech. 63 2009 512 520
8. P. Ebrahimnejad, R. Dinarvand, S.A. Sajadi, M.R. Jafari, F. Movaghari, and F. Atyabi Development and validation of an ion-pair HPLC chromatography for simultaneous determination of lactone and carboxylate forms of SN-38 in nanoparticles J. Food Drug Anal. 17 2009 246 256
9. P. Ebrahimnejad, R. Dinarvand, A. Sajadi, M.R. Jaafari, A.R. Nomani, E. Azizi, M. Rad-Malekshahi, and F. Atyabi Preparation and in vitro evaluation of actively targetable nanoparticles for SN-38 delivery against HT29 cell lines Nanomedicine: NBM. 6 2010 478 485
10. F. Esmaeili, M. Hosseini-Nasr, M. Rad-Malekshahi, N. Samadi, F. Atyabi, and R. Dinarvand Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles Nanomedicine: NBM. 3 2007 161 167 (Pubitemid 46908907)
11. F. Esmaeili, M.H. Ghahremani, B. Esmaeili, M.R. Khoshayand, F. Atyabi, and R. Dinarvand PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution Int. J. Pharm. 349 2008 249 255 (Pubitemid 350299701)
12. J. Fiegel, J. Fu, and J. Hanes Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs J. Control. Rel. 96 2004 411 423 (Pubitemid 38553920)
13. M. Higaki, T. Ishihara, N. Izumo, M. Takatsu, and Y. Mizushima Treatment of experimental arthritis with poly(dl-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate Ann. Rheum. Dis. 64 2005 1132 1136 (Pubitemid 41113345)
14. S.H. Kim, J.H. Jeong, K.W. Chun, and T.G. Park Target-specific cellular uptake of PLGA nanoparticles coated with poly(l-lysine)-poly(ethylene glycol)-folate conjugate Langmuir 21 2005 8852 8857 (Pubitemid 41396646)
15. F. Koizumi, M. Kitagawa, T. Negishi, T. Onda, S. Matsumota, and T. Hamaguchi Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumours Cancer Res. 66 2006 10048 10056 (Pubitemid 44672058)
16. N. Koshkina, J. Waldrep, and V. Knight Camptothecins and lung cancer: improved delivery systems by aerosol Curr. Cancer Drug Targets 3 2003 251 264 (Pubitemid 36944259)
17. R. Kunii, H. Onishi, and Y. Machida Preparation and antitumour characteristics of PLA/(PEG-PPG-PEG) nanoparticles loaded with camptothecin Eur. J. Pharm. Biopharm. 67 2007 9 17 (Pubitemid 46991341)
18. R. Kunii, H. Onishi, K. Ueki, K. Koyama, and Y. Machida Particle characteristics and biodistribution of camptothecin-loaded PLA/(PEG-PPG-PEG) nanoparticles Drug Deliv. 15 2008 3 10
19. Y. Machida, H. Onishi, Y. Kato, and Y. Machida Efficacy of irinotecan-containing nanoparticles prepared using poly(dl-lactic acid) and poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) against M5076 tumour in the early liver metastatic stage STP Pharma. Sci. 13 2003 225 230 (Pubitemid 37337346)
20. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumour vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Rel. 65 2000 271 284 (Pubitemid 30122932)
21. S.M. Moghimi, A.C. Hunter, and J.C. Murray Long-circulating and targetspecific nanoparticles: theory to practice Pharmacol. Rev. 53 2001 283 318 (Pubitemid 32476118)
22. L. Mu, T.A. Elbayoumi, and V.P. Torchilin Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-α-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin Int. J. Pharm. 306 2005 142 149 (Pubitemid 41643148)
23. T. Oguma Antitumour drug processing topoisomerase I inhibition: applicable separation methods J. Chromatogr. B 764 2001 49 58 (Pubitemid 33044659)
24. H. Onishi, Y. Machida, and Y. Machida Antitumour properties of irinotecan-containing nanoparticles prepared using poly (dl-lactic acid) and poly (ethylene glycol)-blockpoly (propylene glycol)-block-poly (ethylene glycol) Biol. Pharm. Bull. 26 2003 116 119
25. J. Park, P.M. Fong, J. Lu, K.S. Russell, C.J. Booth, W.M. Saltzman, and T.M. Fahmy PEGylated PLGA nanoparticles for the improved delivery of doxorubicin Nanomedicine: NBM. 5 2009 410 418
26. V. Peikov, S. Ugwu, M. Parmar, A. Zhang, and I. Ahmad pH-dependent association of SN-38 with lipid bilayersof a novel liposomal formulation Int. J. Pharm. 270 2004 93 107
27. K. Sano, M. Yoshikawa, S. Hayasaka, K. Satake, Y. Ikegami, and H. Yoshida Simple non-ion-paired high-performance liquid chromatographic method for simultaneous quantitation of C and L forms of 14 new camptothecin derivatives J. Chromatogr. B 795 2003 25 34 (Pubitemid 37289422)
28. C.E. Soma, C. Dubernet, G. Barratt, S. Benita, and P. Couvreur Investigation of the role of macrophages on the cytotoxicity of doxorubicin and doxorubicin-loaded nanoparticles on M5076 cells in vitro J. Control. Rel. 68 2000 283 289 (Pubitemid 30488905)
29. A.V. Vergoni, G. Tosi, R. Tacchi, M.A. Vandelli, A. Bertolini, and L. Costantino Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution Nanomedicine: NBM. 5 2009 369 377
30. J. Williams, R. Lansdown, R. Sweitzer, M. Romanowski, R. LaBella, and R. Ramaswamia Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors J. Control. Rel. 91 2003 167 172 (Pubitemid 37288887)
31. H.S. Yoo, and T.G. Park Folate receptor targeted biodegradable polymeric doxorubicin micelles J. Control. Rel. 96 2004 273 283 (Pubitemid 38481509)
32. H. Yoshizawa, S. Nishino, K. Shiomori, S. Natsugoe, T. Aiko, and Y. Kitamura Surface morphology control of polylactide microspheres enclosing irinotecan hydrochloride Int. J. Pharm. 296 2005 112 116 (Pubitemid 40693379)
33. J.A. Zhang, T. Xuan, M. Parmar, L. Parmer, S. Ugwu, S. Ali, and I. Ahmad Development and characterization of a novel liposome-based formulation of SN-38 Int. J. Pharm. 270 2004 93 107 (Pubitemid 38077091)
34. H. Zhao, and L.Y.L. Yung Selectivity of folate conjugated polymer micelles against different tumour cells Int. J. Pharm. 349 2008 256 268 (Pubitemid 350299702)